Profil
Jaques Arend held positions as Medical Director at Kendle International LLC and Grünenthal NV, and as Principal at Smithkline Beecham Plc, Novo Nordisk A, and Yamanouchi Pharma SA. He also served as Vice President-Clinical Development at AM-Pharma BV from 2000 to 2012.
Ehemalige bekannte Positionen von Jaques Arend
| Unternehmen | Position | Ende |
|---|---|---|
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | - |
Grünenthal NV
 Grünenthal NV Pharmaceuticals: MajorHealth Technology Grünenthal NV engages in the manufacture of pharmaceuticals and drugs. The company was founded in 1946 and is headquartered in Sint-Stevens-Woluwe, Belgium. | Technik-/Wissenschafts-/F&E-Leiter | - |
Yamanouchi Pharma SA
 Yamanouchi Pharma SA Pharmaceuticals: MajorHealth Technology Yamanouchi Pharma SA manufactures and distributes pharmaceutical products. It operates as a subsidiary of Astellas Pharma, Inc. The company was founded in 1993 and is headquartered in Madrid, Spain. | Corporate Officer/Principal | - |
Kendle International LLC
 Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Technik-/Wissenschafts-/F&E-Leiter | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| Private Unternehmen | 5 |
|---|---|
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Kendle International LLC
Kendle International LLC Miscellaneous Commercial ServicesCommercial Services Kendle International LLC provides research and development services to biopharmaceutical companies by offering value-added clinical research services and proprietary information technology. The company was founded in 1981 and is headquartered in Cincinnati, OH. | Commercial Services |
Yamanouchi Pharma SA
Yamanouchi Pharma SA Pharmaceuticals: MajorHealth Technology Yamanouchi Pharma SA manufactures and distributes pharmaceutical products. It operates as a subsidiary of Astellas Pharma, Inc. The company was founded in 1993 and is headquartered in Madrid, Spain. | Health Technology |
Grünenthal NV
Grünenthal NV Pharmaceuticals: MajorHealth Technology Grünenthal NV engages in the manufacture of pharmaceuticals and drugs. The company was founded in 1946 and is headquartered in Sint-Stevens-Woluwe, Belgium. | Health Technology |
